Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

How to apply for vascepa's patient assistance?
How often should lurbinectedin's long term effects be monitored?
Guselkumab patent expiration?
Alogliptin benzoate cost?
Dabrafenib patent expiration?

Montelukast classification of drug?

See the DrugPatentWatch profile for Montelukast

Montelukast is classified as an antileukotriene drug.

- Pharmacologic class: Leukotriene receptor antagonist (LTRA), specifically a selective antagonist of the cysteinyl leukotriene receptor 1 (CysLT1).
- Therapeutic class: Antiasthmatic and antiallergy agent.
- Mechanism: It competitively blocks LTD4 (and other cysteinyl leukotrienes) at the CysLT1 receptor, reducing bronchoconstriction and inflammation.



Other Questions About Montelukast :

montelukast api market analysis Montelukast api market analysis? Montelukast sodium? Montelukast intermediate market size? Us montelukast api market? Montelukast api? What are the psychiatric warnings for montelukast?